Tetrabenazine and Hyperthyroidism - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism is reported as a side effect among people who take Tetrabenazine (tetrabenazine), especially for people who are male, 50-59 old, also take Norvasc, and have High blood pressure.

The phase IV clinical study analyzes which people have Hyperthyroidism when taking Tetrabenazine. It is created by eHealthMe based on reports of 1,576 people who have side effects when taking Tetrabenazine from the FDA, and is updated regularly.

What is Tetrabenazine?

Tetrabenazine has active ingredients of tetrabenazine. eHealthMe is studying from 1,580 Tetrabenazine users. Check the latest studies of Tetrabenazine.

What is Hyperthyroidism?

Hyperthyroidism (over activity of the thyroid gland) is found to be associated with 974 drugs and 1,438 conditions by eHealthMe. Check the latest studies of Hyperthyroidism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 28, 2026

1,576 people reported to have side effects when taking Tetrabenazine.
Among them, 11 people (0.7%) have Hyperthyroidism.

Could Tetrabenazine cause Hyperthyroidism?

Among these 11 people:

What is the gender of people who have Hyperthyroidism when taking Tetrabenazine? *

female: 45.45 %
male: 54.55 %

What is the age of people who have Hyperthyroidism when taking Tetrabenazine? *

What are other drugs people take besides Tetrabenazine? *

What are other side effects people have besides Hyperthyroidism? *

Dyskinesia (abnormality or impairment of voluntary movement): 10 people, 90.91%
Fatigue (feeling of tiredness): 10 people, 90.91%
Muscle Spasms (muscle contraction): 8 people, 72.73%
Agitation (state of anxiety or nervous excitement): 7 people, 63.64%
Pain: 7 people, 63.64%
Flatulence (flatus expelled through the anus): 7 people, 63.64%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 7 people, 63.64%
Hypervigilance: 6 people, 54.55%
Mood Swings (an extreme or rapid change in mood): 6 people, 54.55%
Poor Quality Sleep: 6 people, 54.55%

What are the existing conditions these people have? *

Neuropathy Peripheral (surface nerve damage): 6 people, 54.55%
Muscle Spasms (muscle contraction): 6 people, 54.55%
High Blood Pressure: 6 people, 54.55%
Depression: 5 people, 45.45%
Belching (release of gas from the digestive tract): 4 people, 36.36%
Weakness: 1 person, 9.09%
Type 2 Diabetes: 1 person, 9.09%
Neuralgia (pain in one or more nerves): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tetrabenazine and have Hyperthyroidism?

- Check whether Hyperthyroidism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tetrabenazine:

Tetrabenazine (1,580 reports)

Hyperthyroidism treatments and more:

Hyperthyroidism (26,833 reports)

Browse all side effects of Tetrabenazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism:

Hyperthyroidism (974 drugs)

Browse all the conditions that are associated with Hyperthyroidism:

Hyperthyroidism (1,438 conditions)

Related publications that referenced our studies

Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .
Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on tetrabenazine (the active ingredients of Tetrabenazine) and Tetrabenazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.